Delivery Order SPE2DB20D2104-SPE2DB25FMWAV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract ceiling value of $10,871.08. This firm fixed-price delivery order, which is scheduled for completion by July 21, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) under a firm fixed-price contract valued at $6,227.92. This non-set-aside award, effective July 22, 2025, with an ultimate completion date of July 23, 2025, represents a routine pharmaceutical procurement to support federal military and healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,386.66 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count containers). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for ultimate completion on July 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.45 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place...
- This delivery order, awarded July 22, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Carvedilol ER 20 mg capsules in quantities of 30 under a firm fixed-price contract valued at $9,214.06. The contract is scheduled for completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and represents a competitive procurement from the vendor's established...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp., a subsidiary of AmerisourceBergen Corporation, to provide 4,563,971,371 units of Carvedilol ER 40 mg capsules in 30-count packages. The $3,397.71 contract has a completion date of March 15, 2024. This delivery order falls under AmerisourceBergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWAVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $1,930.81. This firm fixed-price delivery order, issued with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. This delivery order is part of AmerisourceBergen Drug Corp's extensive pharmaceutical supply portfolio supporting federal military and veteran healthcare systems. The contractor supplies a comprehensive range of medications, medical devices, and healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The award demonstrates the contractor's capability to meet federal procurement requirements for critical pharmaceutical products on a competitive basis, contributing to the broader DLA Pharmaceutical Prime Vendor Global Program that supports worldwide military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/21/25 |